BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Early pregnancy factor
,
Clofibrate
,
rs4950928
,
BRCA1
,
T cell differentiation
,
Obesity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CD5 antigen
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Loading...
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Viral enteritis
Sepsis due to Escherichia coli
Sepsis due to Gram negative bacteria
Social environment related disease
Intestinal infectious disease
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
ferulic acid
gp50 protein, Schistosoma
p40 egg antigen, Schistosoma
brivanib alaninate
serum albumin, bovine (152-168)
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Notch1
Ahr
MTF2
ABO
PIGA
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
CD5-Negative Primary Mantle Cell Lymphoma Presenting with a Bilateral Conjunctival Mass: A Potential…
CD5+ diffuse large B-cell lymphoma has heterogeneous clinical features and poor prognosis: a single-…
CD5-negative chronic lymphocytic leukemia: Does this entity really exist?
CD5-positive primary diffuse large B-cell lymphoma of the breast: A case report.
B-Lymphoblastic Leukemia With Aberrant CD5 Expression.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressin…
A Study of MT-101 in Subjects With CD5+ Relapsed/Refractory TCL
Lenalidomide in Comb w/Rituximab for Pts w/CD5+/CD20+ Hem Malignancies Who Relapse/Progress After Ri…
Abbreviated 3 Cycles of Rituximab Plus CHOP(Cyclophosphamide, Adriamycin, Vincristine, and Prednisol…
Anti-CD5 CAR T Cells for Relapsed/Refractory T Cell Malignancies
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ